Phibro, Epitopix form poultry vaccine partnership

Published on: Nov 20, 2013

Phibro Animal Health Corp. and Epitopix LLC have entered into a partnership to manufacture and market biological products for chickens in the U.S. based on Epitopix's novel SRP (siderophore receptor proteins) technology. Additionally, the parties intend to collaborate on a global basis to develop unique poultry biological products based on this technology, the announcement said.

"We are very excited about combining the novel technology and experience of Epitopix with Phibro's global expertise in developing innovative poultry vaccines, supported in the field by Phibro's sales and technical service team," said Larry Miller, Phibro Animal Health president.

"This partnership will help poultry producers access a superior immunological solution for control of salmonella, Escherichia coli and other gram-negative pathogens," Epitopix general manager Jim Sandstrom added.